Symbol
|
WEVLTQ | RMASRV | XRMLTQ | AAUYSQ | RMBBNV | ABBZSQ | RMBWDV | ABJASQ | BTJBKB | ZPRLTQ | OCGRCH | RMAZBV | RMAKXV | ONHRCH | OOJRCH | AARUTQ | AAXSTQ | Z24BPZ | RMAJ2V | OZURCH |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nom | Multi Reverse Convertible | Multi Vonti | Worst of Reverse Convertible | Reverse Convertible | Multi Vonti | Reverse Convertible | Multi Vonti | Multi Reverse Convertible | Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Multi Vonti | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Reverse Convertible | Worst of Reverse Convertible | ZKB Reverse Convertible on worst of Last Look | Multi Vonti | Worst of Callable Reverse Convertible |
Sous-jacent
|
Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / UBS Group AG | Mitsubishi UFJ Financial Group Inc. / UBS Group AG | Swiss Life Hldg. N / Swiss RE AG / UBS Group AG / Zurich Insurance Group AG | Partners Group Hldg. AG / UBS Group AG | Roche GS / Swisscom / UBS | Nestlé / Novartis / Roche GS / UBS / Zurich | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Nestlé / Novartis / Roche GS / UBS / Zurich | Givaudan / Novartis AG / Roche AG / Sandoz Group AG / Sonova Hldg. AG / UBS Group AG | Geberit AG / Partners Group Hldg. AG / Sika AG / Sonova Hldg. AG / UBS Group AG | Lonza Group N / Nestlé S.A. / Roche AG / UBS Group AG | Barry Callebaut AG / Nestlé S.A. / Roche AG / Swiss RE AG / UBS Group AG | JPMorgan Chase & Co. / Morgan Stanley / UBS Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | ABB / Lonza / UBS | Nestlé / Roche GS / UBS | Geberit AG / Nestlé S.A. / Novartis AG / UBS Group AG / Zurich Insurance Group AG |
Emetteur
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Échéance
|
31.03.2028 | 10.02.2026 | 06.07.2026 | 18.08.2025 | 17.11.2025 | 01.12.2025 | 27.07.2026 | 08.04.2027 | 08.04.2027 | 23.04.2027 | 26.04.2027 | 28.05.2025 | 08.06.2026 | 08.07.2026 | 15.07.2026 | 13.08.2026 | 13.09.2027 | 16.09.2025 | 17.09.2025 | 07.07.2026 |
Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Prix d'exercise
|
49,63 | 183,53 | 17,57 | 55,367 | 15,41 | 166,845 | 60,97 | 43,685 | 43,685 | 42,50 | 52,5202 | 19,21 | 357,80 | 55,032 | 158,145 | 16,674 | 49,30 | 407,40 | 214,08 | 403,92 |
rendement max. p.a. | 4,62% | 6,36% | - | -0,47% | 5,87% | 3,37% | 8,45% | 6,08% | 5,46% | 4,72% | 5,97% | 9,06% | 11,70% | 6,42% | 30,46% | 9,96% | 4,56% | 10,43% | 11,61% | 9,12% |
Demande | 99,61 | 100,20 | 201,36 | 101,17 | 99,60 | 100,88 | 96,90 | 97,67 | 97,48 | 98,98 | 96,33 | - | 94,90 | 97,49 | 77,28 | 98,66 | 99,23 | - | 98,30 | 96,11 |
Offre | 100,41 | 103,00 | 203,38 | 101,98 | 102,40 | 101,69 | 99,70 | 98,47 | 98,28 | 99,78 | 97,13 | - | 96,00 | 98,29 | 78,06 | 99,46 | 100,03 | - | 101,10 | 96,91 |